N. Witte - Jun 13, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Lillian Smith, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 05:00 PM
Previous filing
Aug 15, 2022
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +74.6K +34.16% $0.00 293K Jun 13, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.